Sections
| Title |
|---|
| Table Of Contents |
| 1 Introduction (Page No. - 21) |
| 1.1 Objectives Of The Study |
| 1.2 Report Description |
| 1.3 Markets Covered |
| 1.4 Stakeholders |
| 1.5 Market Scope |
| 1.6 Research Methodology |
| 1.6.1 Market Size Estimation & Data Triangulation |
| 1.6.2 Key Data Points From Secondary Sources |
| 1.6.3 Key Data Points From Primary Sources |
| 1.6.4 Assumptions |
| 2 Executive Summary (Page No. - 34) |
| 3 Premium Insights (Page No. - 40) |
| 3.1 Market Size |
| 3.2 Market Dynamics |
| 3.3 In-Vitro Toxicity Testing Market Size Snapshot |
| 3.4 In-Vitro Toxicity Testing, Geographic Analysis By Industry |
| 3.5 In-Vitro Toxicity Testing Market Size, By Technology |
| 3.6 In-Vitro Toxicity Testing Market Size, By Method |
| 3.7 In-Vitro Toxicity Testing Market, By Application |
| 4 Market Overview (Page No. - 47) |
| 4.1 Introduction |
| 4.2 Market Segmentation |
| 4.3 Market Dynamics |
| 4.3.1 Drivers |
| 4.3.1.1 Dearth Of Publicly Accessible Databases to Facilitate The Use Of In Vitro Test Methods |
| 4.3.1.2 New and Promising Technologies to Propel Market |
| 4.3.1.3 Technological Advancements and Shifting Focus to Innovative Approaches Of 3d Cell Cultures Are Driving The Cell Culture Technology Market |
| 4.3.1.4 Opposition to Animal Testing Will Help Shift The Focus to In Vitro Testing |
| 4.3.2 Restraints |
| 4.3.2.1 Technological Disadvantages Associated With In Vitro Tests Limit Their Use |
| 4.3.2.2 In Vitro Models Cannot Detect Autoimmunity and Immunostimulation |
| 4.3.2.3 Predictive Ability Of In Vitro Testing Leads to Decreasing Adoption Of These Tests |
| 4.3.3 Opportunities |
| 4.3.3.1 The Toxicology In The 21st Century (Tox21) Program |
| 4.3.3.2 Increasing Drug Discovery and Innovation and Modernization in The Market |
| 4.3.3.3 Growing Demand For In Vitro Toxicology in The European Market |
| 4.3.4 Threats |
| 4.3.4.1 Reluctance Of Regulatory Authorities to Consider Alternate Methods For Proving Safety and Efficacy |
| 4.4 Burning Issues |
| 4.4.1 Validation Of New In Vitro Methods |
| 4.4.2 Differences in Opinion Between The U.S. and Eu Regulatory Authorities |
| 4.5 Winning Imperatives |
| 4.5.1 3d Human Hepatocyte Models to Boost The In Vitro Testing Market |
| 5 By Industry (Page No. - 60) |
| 5.1 Introduction |
| 5.2 Diagnostics |
| 5.2.1 Diagnostics, By Type |
| 5.2.1.1 Forensics |
| 5.2.1.2 Drug Abuse & Workplace Drug Testing |
| 5.2.2 Diagnostics, By Sample |
| 5.2.2.1 Urine Screening |
| 5.2.2.2 Alcohol Screening |
| 5.2.2.3 Oral Fluid Screening |
| 5.2.2.4 Hair Screening |
| 5.2.2.5 Others |
| 5.3 Cosmetics & Household Products |
| 5.4 Pharmaceutical Industry |
| 5.5 Chemicals Industry |
| 5.6 Food Industry |
| 6 By Technology (Page No. - 86) |
| 6.1 Introduction |
| 6.1.1 Cell Culture Technology |
| 6.1.1.1 Primary Monolayer and Three-Dimensional Cell Cultures |
| 6.1.2 High Throughput Technologies |
| 6.1.2.1 High Throughput Toxicity Testing |
| 6.1.2.2 The Epa Toxcast Program |
| 6.1.3 Molecular Imaging Technologies |
| 6.1.3.1 Molecular Imaging Technologies |
| 6.1.3.2 High Content Imaging Technologies |
| 6.1.4 Omics Technologies |
| 6.1.4.1 Genomics |
| 6.1.4.2 Toxicogenomics |
| 6.1.4.3 Proteomics |
| 6.1.4.4 Metabolomics |
| 7 By Application (Page No. - 108) |
| 7.1 Introduction |
| 7.2 Systemic Toxicity |
| 7.3 Dermal Toxicity |
| 7.4 Ocular Toxicity |
| 7.5 Endocrine Disruption (Reproductive/Developmental Toxicity) |
| 7.6 Others (Admet, Organ-Specific Toxicity, Drug-Drug Interactions, Target/Pathway Assays, & Ecotoxicity) |
| 7.6.1 Admet (Pharmacokinetics & Metabolism Testing) |
| 7.6.2 Organ-Specific Toxicity |
| 7.6.3 Drug-Drug Interactions |
| 7.6.4 Target/Pathway Assays |
| 7.6.5 Ecotoxicity |
| 8 By Method (Page No. - 124) |
| 8.1 Introduction |
| 8.2 Cellular Assays |
| 8.3 Biochemical Assays |
| 8.4 In Silico Methods |
| 8.5 Ex Vivo Models |
| 9 Geographic Analysis (Page No. - 137) |
| 9.1 Introduction |
| 9.2 Europe |
| 9.3 North America |
| 9.4 Asia |
| 9.5 Rest Of The World (ROW) |
| 10 Competitive Landscape (Page No. - 168) |
| 10.1 Introduction |
| 10.2 Competitive Landscape, 2011-March 2014 |
| 10.3 New Product Launches |
| 10.4 Mergers & Acquisitions |
| 10.5 Agreements, Partnerships & Collaborations |
| 10.6 Expansions |
| 10.7 Other Developments |
| 11 Company Profiles (Business Overview, Products & Services, Key Strategy, Recent Developments, Mnm View)* (Page No. - 191) |
| 11.1 Agilent Technologies, Inc. |
| 11.2 Alere, Inc. |
| 11.3 Bio-Rad Laboratories, Inc. |
| 11.4 Bioreliance, Inc. (A Subsidiary Of Sigma-Aldrich Corporation) |
| 11.5 Catalent |
| 11.6 Charles River Laboratories International, Inc. |
| 11.7 Covance, Inc. |
| 11.8 Cyprotex |
| 11.9 Eurofins Scientific |
| 11.1 GE Healthcare |
| 11.11 Life Technologies Corporation (Thermo Fisher Scientific) |
| 11.12 Quest Diagnostics |
| *Details On Products & Services, Key Strategy, & Recent Developments Might Not Be Captured in Case Of Unlisted Companies. |
| List Of Tables (67 Tables) |
| Table 1 In-Vitro Toxicology/Toxicity Testing, By Geography, 2011-2013 ($Million) |
| Table 2 Global Market, By Industry, 2011-2018 ($Million) |
| Table 3 Global Market For Diagnostics Industry, By Type, 2011-2018 ($Million) |
| Table 4 In Vitro Toxicology Testing Market For Diagnostics Industry, By Geography, 2011-2018 ($Million) |
| Table 5 In-Vitro Toxicology Testing Market For Forensics, By Geography, 2011-2018 ($Million) |
| Table 6 Market For Drug Abuse & Workplace Drug Testing, By Geography, 2011-2018 ($Million) |
| Table 7 Market For Diagnostics Industry, By Sample, 2011-2018 ($Million) |
| Table 8 Urine Sample Testing Market, By Geography, 2011-2018 ($Million) |
| Table 9 Alcohol Sample Testing Market, By Geography, 2011-2018 ($Million) |
| Table 10 Oral Sample Testing Market, By Geography, 2011-2018 ($Million) |
| Table 11 Hair Sample Testing Market, By Geography, 2011-2018 ($Million) |
| Table 12 Others Sample Testing Market, By Geography, 2011-2018 ($Million) |
| Table 13 In Vitro Toxicology Testing Market For Cosmetics & Household Industry, By Geography, 2011-2018 ($Million) |
| Table 14 In Vitro Toxicology Testing Market For Pharmaceutical Industry, By Geography, 2011-2018 ($Million) |
| Table 15 Market For Chemical Industry, By Geography, 2011-2018 ($Million) |
| Table 16 Market For Food Industry, By Geography, 2011-2018 ($Million) |
| Table 17 Global In Vitro Toxicology Testing Market, By Technology, 2011-2018 ($Million) |
| Table 18 In-Vitro Toxicology Testing Market For Cell Culture Technology, By Geography, 2011-2018 ($Million) |
| Table 19 Global In-Vitro Toxicology Testing Market For Cell Culture Technology, By Industry, 2011-2018 ($Million) |
| Table 20 In Vitro Toxicology Testing Market For High Throughput Technology, By Geography, 2011-2018 ($Million) |
| Table 21 Global Market For High Throughput Technology, By Industry, 2011-2018 ($Million) |
| Table 22 Market For Molecular Imaging Technology, By Geography, 2011-2018 ($Million) |
| Table 23 Global Market For Molecular Imaging Technology, By Industry, 2011-2018 ($Million) |
| Table 24 Market For Omics Technologies, By Geography, 2011-2018 ($Million) |
| Table 25 Global Market For Omics Technologies, By Industry, 2011-2018 ($Million) |
| Table 26 Global Market, By Application, 2011-2018 ($Million) |
| Table 27 In Vitro Toxicity Testing Market For Systemic Toxicology, By Geography, 2011-2018 ($Million) |
| Table 28 Market For Dermal Toxicology, By Geography, 2011-2018 ($Milllion) |
| Table 29 Market For Ocular Toxicology, By Geography, 2011-2018 ($Milllion) |
| Table 30 Market For Endocrine Disruption, By Geography, 2011-2018 ($Milllion) |
| Table 31 Market For Other Applications, By Geography, 2011-2018 ($Milllion) |
| Table 32 In-Vitro Toxicology Testing Market, By Method, 2011-2018 ($Million) |
| Table 33 Primary Cell Culture Advantages & Limitations |
| Table 34 In Vitro Toxicity Testing Market For Cellular Assays, By Geography, 2011-2018 ($Million) |
| Table 35 In Vitro Toxicity Testing Market For Biochemical Assays, By Geography, 2011-2018 ($Million) |
| Table 36 In Vitro Toxicity Testing Market For In Silico Methods, By Geography, 2011-2018 ($Million) |
| Table 37 In Vitro Toxicity Testing Market For Ex Vivo Methods, By Geography, 2011-2018 ($Million) |
| Table 38 In Vitro Toxicology Market, By Geography, 2011-2018 ($Million) |
| Table 39 Europe: Market, By Industry, 2011-2018 ($Million) |
| Table 40 Europe: Market For Diagnostics Industry, By Sample, 2011-2018 ($Million) |
| Table 41 Europe: Market For Diagnostics Industry, By Type, 2011-2018 ($Million) |
| Table 42 Europe: Market, By Technology, 2011-2018 ($Million) |
| Table 43 Europe: Market, By Method, 2011-2018 ($Million) |
| Table 44 Europe: Market, By Application, 2011-2018 ($Million) |
| Table 45 North America: Market, By Industry, 2011-2018 ($Million) |
| Table 46 North America: Market For Diagnostics Industry, By Sample, 2011-2018 ($Million) |
| Table 47 North America: In Vitro Toxicology Testing Market For Diagnostics Industry, By Type, 2011-2018 ($Million) |
| Table 48 North America: Market, By Technology, 2011-2018 ($Million) |
| Table 49 North America: Market, By Method, 2011-2018 ($Million) |
| Table 50 North America: Market, By Application, 2011-2018 ($Million) |
| Table 51 Asia: Market, By Industry, 2011-2018 ($Million) |
| Table 52 Asia: Market For Diagnostics Industry, By Sample, 2011-2018 ($Million) |
| Table 53 Asia: Market For Diagnostics Industry, By Type, 2011-2018 ($Million) |
| Table 54 Asia: Market, By Technology, 2011-2018 ($Million) |
| Table 55 Asia: Market, By Method, 2011-2018 ($Million) |
| Table 56 Asia: Market, By Application, 2011-2018 ($Million) |
| Table 57 ROW: Market, By Industry, 2011-2018 ($Million) |
| Table 58 ROW: Market For Diagnostics Industry, By Sample, 2011-2018 ($Million) |
| Table 59 ROW: Market For Diagnostics Industry, By Type, 2011-2018 ($Million) |
| Table 60 ROW: Market, By Technology, 2011-2018 ($Million) |
| Table 61 ROW: Market, By Method, 2011-2018 ($Million) |
| Table 62 ROW: Market, By Application, 2011-2018 ($Million) |
| Table 63 New Product Launches, 2011-2014 |
| Table 64 Mergers & Acquisitions, 2011-2014 |
| Table 65 Agreements, Partnerships, & Collaborations, 2011-2014 |
| Table 66 Expansions, 2011-2014 |
| Table 67 Other Developments, 2011-2014 |
| List Of Figures (25 Figures) |
| Figure 1 Market Crackdown & Data Triangulation |
| Figure 2 Market Forecasting Model |
| Figure 3 In Vitro Toxicology Testing, By Industry, 2013 ($Million) |
| Figure 4 Global Market, By Technology, 2013 ($Million) |
| Figure 5 Market Size, ($Million) |
| Figure 6 Market Dynamics |
| Figure 7 Market Size Snapshot, 2013 ($Million) |
| Figure 8 Geographic Analysis, By Industry, 2013 ($Million) |
| Figure 9 Global Market Size, By Technology, 2013 ($Million) |
| Figure 10 Global Market Size, By Method, 2013 ($Million) |
| Figure 11 Opportunity Matrix: Global Market, By Application, 2013 |
| Figure 12 Market Crackdown & Data Triangulation |
| Figure 13 Global Market, By Industry,2013 ($Million) |
| Figure 14 Global Market, By Technology, 2013 Vs 2018 ($Million) |
| Figure 15 Primary Cell Cultures Advantages & Disadvantages |
| Figure 16 High Throughput Technology Advantages & Disadvantages |
| Figure 17 Molecular Imaging Technologies Advantages & Disadvantages |
| Figure 18 High Content Imaging Technologies Advantages & Disadvantages |
| Figure 19 Genomics Advantages & Disadvantages |
| Figure 20 Proteomics Advantages & Disadvantages |
| Figure 21 Metabolomics Advantages & Disadvantages |
| Figure 22 Global Market, By Application, 2013 ($Million) |
| Figure 23 Opportunity Matrix: Global Market, By Method, 2013 |
| Figure 24 In Vitro Toxicology Testing Market, By Geography, 2013 |